骨质疏松治疗药物研究新进展
摘要
骨质疏松是一种以骨量减少、伴骨组织微结构破损引起股脆性危险性增高的全身代谢性骨病。随着医疗技术的不断提高,针对骨质疏松症,一些新的治疗方法逐渐获得人们的认可,在具体治疗策略上主要在于抑制骨吸收且增加骨形成。在本次研究中,就对临床治疗骨质疏松症的最新治疗药物做一综述,旨在给相关的医师提供良好参考。
引文
[1]甄东,邱冰.唑来膦酸治疗35例原发性骨质疏松症的疗效及观察[J].中国骨质疏松杂志,2012,18(2):166-168.
[2]Hannon R A,Clack G,Rimmer M,et al.Effects of the Src kinase inhibitor saracatinib(AZD0530)on bone turnover in healthy men:a randomized,double-blind,placebo-controlled,multipleascending-dose phase I trial.[J].Journal of Bone&Mineral Research,2012,27(6):1435-1435.
[3]Li X,Ominsky M S,Sun N,et al.Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength[J].Journal of Bone&Mineral Research,2008,23(6):860.
[4]秦艳娥,陈彪.锝[99Tc]亚甲基二膦酸盐治疗骨质疏松症的研究进展[J].西北药学杂志,2018,33(1):140-142.
[2]Hannon R A,Clack G,Rimmer M,et al.Effects of the Src kinase inhibitor saracatinib(AZD0530)on bone turnover in healthy men:a randomized,double-blind,placebo-controlled,multipleascending-dose phase I trial.[J].Journal of Bone&Mineral Research,2012,27(6):1435-1435.
[3]Li X,Ominsky M S,Sun N,et al.Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength[J].Journal of Bone&Mineral Research,2008,23(6):860.
[4]秦艳娥,陈彪.锝[99Tc]亚甲基二膦酸盐治疗骨质疏松症的研究进展[J].西北药学杂志,2018,33(1):140-142.